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The ability of Salmonella to cause disease depends
on metabolic activities and virulence factors. Here,
we show that a key metabolic protein, EIIAGlc, is
absolutely essential for acute infection, but not
for Salmonella survival, in a mouse typhoid fever
model. Surprisingly, phosphorylation-dependent
EIIAGlc functions, including carbohydrate transport
and activation of adenylate cyclase for global regula-
tion, do not explain this virulence phenotype.
Instead, biochemical studies, in vitro secretion and
translocation assays, and in vivo genetic epistasis
experiments suggest that EIIAGlc binds to the type
three secretion system 2 (TTSS-2) involved in sys-
temic virulence, stabilizes its cytoplasmic part
including the crucial TTSS-2 ATPase, and activates
virulence factor secretion. This unexpected role
of EIIAGlc reveals a striking direct link between
central Salmonella metabolism and a crucial viru-
lence mechanism.INTRODUCTION
Salmonella enterica causes diarrhea but also more life-
threatening systemic diseases such as typhoid fever in humans
and animals (Coburn et al., 2007). Salmonella growth and
disease progression depends on Salmonellametabolic activities
and virulence factors (Haraga et al., 2008; Kuhle and Hensel,
2004; Steeb et al., 2013), and both types of activities are likely
coordinated during infection (Go¨rke and Stu¨lke, 2008; Poncet
et al., 2009).
Phosphoenolpyruvate:carbohydrate phosphotransfer trans-
port systems (PTSs) may participate in this coordination
because they mediate nutrient uptake, control global meta-
bolism, and modulate virulence in diverse pathogens (Deutscher
et al., 2006; Poncet et al., 2009). PTSs catalyze sugar uptake
through sugar-specific permeases called enzymes II with cyto-
plasmic domains EIIA and EIIB and membrane-crossing domain
EIIC (and sometimes EIID). During transport, the sugar is phos-1426 Cell Reports 7, 1426–1433, June 12, 2014 ª2014 The Authorsphorylated by phosphoenolpyruvate (PEP) through intermediary
phosphate acceptors including general enzyme I and HPr. The
phosphorylation status of PTS components depends on avail-
ability of sugar substrates and glycolysis/gluconeogenesis
fluxes that determine the PEP/pyruvate ratio. PTS phos-
phorylation thus reflects the general metabolic state, and this
is exploited by many bacteria as sensory input to regulate
metabolism, respiration, motility, and virulence (Deutscher
et al., 2006).
As an example, the PTS component EIIAGlc (encoded by the
carbohydrate repression resistance gene, crr) mediates uptake
of glucose, N-acetyl-muramic acid, and yet unidentified sugars.
In absence of these substrates, phosphorylated EIIAGlc (EIIAGlc-
P) accumulates and activates adenylate cyclase (CyaA), result-
ing in increased cyclic AMP (cAMP) levels. cAMP activates the
cAMP receptor protein (CRP; also called catabolite gene acti-
vator protein), a transcription factor that modulates expression
of several hundred genes (Deutscher et al., 2006). In addition
to CyaA, EIIAGlc directly modulates the activity of several other
metabolic proteins including glycerol kinase (Hurley et al.,
1993), the fermentation/respiration switch protein (FrsA) (Koo
et al., 2004), PtsN (Rabus et al., 1999), and MalK (Chen et al.,
2013).
In this study, we discovered a major role of EIIAGlc in Salmo-
nella virulence in a mouse infection model that closely mimics
human typhoid fever (Santos et al., 2001).
RESULTS
EIIAGlc Is Essential for Systemic Salmonella Virulence
Salmonella crr lacking the gene encoding EIIAGlc, has a
moderate growth defect in cell culture infections (Bowden
et al., 2009). To determine the in vivo relevance of EIIAGlc, we
infected mice with a mixture of wild-type Salmonella enterica
serovar Typhimurium SL1344 and a crr deletion mutant.
Wild-type outcompeted the crr mutant 250-fold within 3 days,
indicating very strong attenuation, and crr complementation in
cis or trans restored full virulence (Figure 1A). The crr mutant
failed to grow in spleen but survived for at least 28 days (Figures
1B and 1C). In contrast, Salmonella crr grew normally in vitro
(Figure S1A). These data establish that EIIAGlc has a crucial
role in Salmonella virulence.
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*** Figure 1. Virulence of Salmonella crr and
Related Mutants
(A) Competitive indices of Salmonella mutants
versus wild-type at day 3 postinfection in mouse
spleen. A log10(competitive index [CI]) value of
0 (equivalent to a CI of 1) represents full virulence.
Data for individual mice and geometric means are
shown. Statistical significance of differences
against wild-type or between mutant pairs was
tested using t test on log-transformed data (***p <
0.001; **p < 0.01; *p < 0.05).
(B) Time course for Salmonella crr (open circles) and
wild-type Salmonella (filled circles). Spleen loads of
individual mice relative to the infection doses are
shown.
(C) Spleen loads for Salmonella crr (open circles),
ssaGH (triangles), and crr ssaGH (diamonds) relative
to the infection doses.
See also Figure S1.Known EIIAGlc Functions Do Not Explain Its Role in
Virulence
EIIAGlc mediates PTS sugar uptake, but this function was
dispensable for Salmonella virulence because a ptsG murP
nagE SL1344_2742 (D4EIIGlc) mutant lacking all EIIAGlc-depen-
dent EIIBC systems as well as NagE (a glucose-type EIICBA
that interacts with EIIAGlc; Vogler and Lengeler, 1988) retained
wild-type virulence (Figure 1A). This was confirmed by the high
virulence of Salmonella carrying a crrH90A allele encoding an
EIIAGlc variant that lacks the crucial phosphorylation site histidine
90 required for sugar transport (Do¨rschug et al., 1984; Figure 1A).
EIIAGlc-P modulates Salmonella gene expression through
activation of CyaA and CRP (both of which are essential for
Salmonella virulence; Curtiss and Kelly, 1987). However, the
high virulence of Salmonella crrH90A (Figure 1A) suggested that
this and other phosphorylation-dependent EIIAGlc functions
were largely dispensable. This was confirmed by the additive de-
fects of cyaA and crrmutations in a cyaA crr double mutant (Fig-
ure 1A), indicating EIIAGlc functions other than CyaA activation.
cAMP and cAMP/CRP are crucial for virulence but can appar-
ently be supported by basal CyaA activities in absence of
EIIAGlc-P (Nelson et al., 1982; You et al., 2013). Indeed,
Salmonella crr and Salmonella crrH90A carrying a CRP-depen-
dent promoter-gfp fusion had substantial GFP fluorescence
in vitro and in vivo, confirming cAMP/CRP activity in absence
of EIIAGlc-P (Figures S1C and S1D). Similarly, Salmonella utiliza-
tion of several relevant nutrients (Steeb et al., 2013) was CRPCell Reports 7, 1426–14dependent but largely EIIAGlc independent
(Figure S1E). Finally, proteome com-
parisons under conditions mimicking
in vivo environments revealed 19 EIIAGlc-
regulated proteins out of 1,254 detected
proteins (Table S1), but none of them was
likely to mediate the crr virulence pheno-
type (Table S1). These data did not support
a critical virulence role of EIIAGlc in gene
regulation in contrast to other PTS compo-
nents (Salmonella EIIBCGlc/type threesecretion system [TTSS]-1 [Lim et al., 2007]; Salmonella
EIIANtr/SsrB [Choi et al., 2010]; Brucella melitensis HPr and
enzyme I/type IV secretion [Dozot et al., 2010]).
EIIAGlc modulates the activity of additional proteins. Analysis
of corresponding Salmonella single and double mutants sug-
gested that none of these interactions could individually explain
the strong crr virulence defect (Figure 1A). This included the
EIIAGlc paralog EIIANtr, which was largely dispensable for
Salmonella systemic virulence, in contrast to oral infections
(Choi et al., 2010). However, these data did not rule out that
simultaneous EIIAGlc interactions with several partners might
together support Salmonella virulence.
EIIAGlc Interacts with the Type III Secretion System
Encoded on SPI-2
EIIAGlc might interact with yet unknown proteins. To explore this
issue, we performed coimmunoprecipitation/mass spectrometry
(coIP/MS) with Salmonella expressing 33FLAG-tagged EIIAGlc.
Comparison with data for a control strain without FLAG-tagged
protein revealed specific enrichment of known interaction part-
ners such as EIICBGlc (encoded by ptsG; Buhr et al., 1994) and
FrsA (Koo et al., 2004), as well as many potential new interaction
partners (Table S2), similar to findings for Vibrio cholerae EIIAGlc
(Pickering et al., 2012). Using a cutoff of five identified peptides,
79 proteins were exclusively found in EIIAGlc-FLAG coIPs,
whereas just three were exclusively found in the controls. Among
the identified 79 specific candidates, there were several subunits33, June 12, 2014 ª2014 The Authors 1427
of the type III secretion system encoded on the Salmonella path-
ogenicity island 2 (TTSS-2), which is essential for Salmonella
virulence (Shea et al., 1996; Figure 2B; Table S2).
It is important to note that we crosslinked complexes using
mild formaldehyde treatment to stabilize them during purifica-
tion. The identified TTSS-2 components could thus represent
direct interaction partners of EIIAGlc or crosslinked proteins
from the same complexes with no direct interaction. These
data have additional caveats: (1) Our controls helped to exclude
false-positive proteins that bind to the anti-FLAG beads used for
immunoprecipitation (IP), but we could not rule out that some
proteins might bind to the FLAG tag on EIIAGlc. (2) We failed to
detect known interaction partners GlpK, HPr, CyaA, MelB, and
MalK, indicating important false negatives. CyaA, MalK, and
MelB were poorly expressed under our experimental conditions.
GlpK and HPr were found in similar amounts in coIPs of Salmo-
nella expressing EIIAGlc-FLAG and controls indicating nonspe-
cific binding. The coIP data thus provided only a first hint about
potential interactions with TTSS-2.
Salmonella crr assembled apparently normal TTSS-2
SsaCDJPRVU core complexes that could be captured with 33
FLAG-tagged SsaD (Figures 2A and 2B; Table S3). However,
several more peripheral subunits were underrepresented
compared to TTSS-2 from wild-type. This included SsaK,
SsaQ, SsaO, SL1344_1344, and the ATPase SsaN, which is
essential for secretion (Cooper et al., 2010; Yoshida et al.,
2014). All these subunits probably localize to the cytoplasmic
part of TTSS-2 (Rey et al., 2005; Yoshida et al., 2014), where
they could interact with EIIAGlc (Wang et al., 2000).
SsaK, SsaN, and SsaO might interact directly based on the
EIIAGlc-FLAG coIP data (Figure 2B), whereas SL1344_1344 and
SsaO were not found to interact with EIIAGlc but might bind to
SsaK, SsaN, or SsaO, or their TTSS-2 association may depend
on EIIAGlc-dependent conformational TTSS-2 states. Several
other components that were pulled down together with EIIAGlc
were assembled in TTSS-2, regardless of EIIAGlc. This could
reflect pull-down of large crosslinked TTSS-2 complexes that
included components with no direct interactions to EIIAGlc.
Finally, the secreted translocon component SseB was also
diminished in Salmonella crr TTSS-2 complexes, and this might
reflect compromised secretion activity in the absence of essen-
tial cytoplasmic subunits.
Underrepresentation of some TTSS-2 subunits was probably
not the result of poor expression. SseB and SsaQ were actually
detected at similar levels in cell lysates of crr and wild-type
(Table S1). SsaK and SL1344_1344 were not detected in cell
lysates presumably because of high sample complexity, but
these subunits are known to be coexpressed from the same
operon (Walthers et al., 2007) as normally abundant SsaH (Table
S1) and normally assembling SsaJ (Table S3). Similarly, SsaN
andSsaOwere not detected in lysates, but they are coexpressed
with normally abundant SsaQ and SsaU (Table S1) and normally
assembled SsaPRUV (Table S3; Walthers et al., 2007).
To further explore EIIAGlc/TTSS-2 interactions, we used a
bacterial two-hybrid system (Karimova et al., 1998) in Salmonella
with libraries containing fragments of all known TTSS-2-associ-
ated genes. We did not find interactions between EIIAGlc and
structural TTSS-2 proteins using this approach. This could1428 Cell Reports 7, 1426–1433, June 12, 2014 ª2014 The Authorsindicate no direct interaction or non-native conformations of
TTSS-2 components and their fragments in fusion proteins that
were not assembled in intact TTSS-2. On the other hand, we
detected EIIAGlc interactions to N-terminal fragments of the
TTSS-2 effectors PipB and PipB2 (Figure 2C). Interactions
were similar for full-length EIIAGlc and EIIAGlc DN16 lacking the
first 16 amino acids required for membrane association (Wang
et al., 2000; Figure S2A). This and other data suggested that
interactions with PipB and PipB2 may play a subordinate part
in the crucial virulence function of EIIAGlc (see below). We there-
fore did not independently verify these interactions.
Together, these data showed that EIIAGlc had limited impact
on TTSS-2 expression or assembly of the core secretion appa-
ratus but stabilized the crucial cytosolic part of TTSS-2 and
might interact with some effectors.
EIIAGlc Is Essential for TTSS-2 Effector Secretion
To determine the impact of EIIAGlc on TTSS-2 function, we
analyzed effector secretion and translocation. Wild-type
Salmonella, a crrH90A mutant (no EIIAGlc phosphorylation), and
a crrH90D mutant (potentially mimicking EIIAGlc-P) all secreted
similar amounts of effectors into axenic culture supernatants
(Figure 3A). Similarly, available carbon sources strongly affected
EIIAGlc phosphorylation status in wild-type Salmonella, as
expected (Figure S2B), but this had no detectable impact on
TTSS-2 secretion (Figures 3A and S2B). However, secretion
was completely abolished in Dcrr (Figure 3A) but restored to
elevated levels by complementation with multicopy crr (Fig-
ure S2C). EIIAGlc interactions with effectors PipB and PipB2
(see above) were not required for TTSS-2 secretion as demon-
strated by normal SteC secretion in Salmonella pipB, pipB2,
and pipB pipB2 mutants (Figure S2D).
Salmonella wild-type and crrH90A, but not Dcrr, translocated
M45-tagged PipB2 (Halici et al., 2008) into the cytoplasm of
infected macrophages (Figure 3B). EIIAGlc D38A or EIIAGlc
D94A with surface alterations close to the phosphorylation site
at histidine 90 (Worthylake et al., 1991) enabled normal PipB2
translocation. In contrast, translocation was abolished in
Salmonella expressing EIIAGlc D38A F41A K69A D94A or EIIAGlc
DN16 (Figure 3C), despite substantial EIIAGlc protein levels in
both strains (Figure S2E). These translocation effects of EIIAGlc
mutations differed from effects on a cAMP/CRP-dependent pro-
moter fusion (Figure 3C), indicating distinct EIIAGlc interaction
surfaces for TTSS-2 and CyaA.
These data show that EIIAGlc is required for secretion through
TTSS-2, whereas secretion of TTSS-1 effectors and flagellin is
independent of EIIAGlc (Figure S2F). TTSS-2 can be activated by
both nonphosphorylated EIIAGlc H90A and EIIAGlc H90D carrying
anegativechargeat thenormalphosphorylationsite,but if EIIAGlc-
P would also activate remains unclear. To address this issue, we
would need assay conditions where Salmonella contains exclu-
sively EIIAGlc-P, but our attempts in this direction using succinate
medium (Hogema et al., 1998) were unsuccessful (Figure S2B).
Activation of TTSS-2 Is the Major Virulence Function
of EIIAGlc in Systemic Salmonellosis
Loss of TTSS-2 activity could explain the strong attenuation of
Salmonella crr. To test this hypothesis, we analyzed genetic
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(A) Proteins recovered by SsaD coIP inSalmonellawild-type- and crr. TTSS-2-associated proteins are labeled with red circles. Proteins with a >2-fold change and
q value < 0.05 are considered significant (upper left and right areas).
(B) Schematic representation of TTSS-2 and likely positions of proteins detected by coIP with EIIAGlc-33FLAG or TTSS-2 subunit SsaD-33FLAG in Salmonella
wild-type (WT) and crr. See also Tables S1, S2, and S3. IM, inner membrane.
(C) Interaction of EIIAGlc with TTSS-2 effector proteins PipB and PipB2 as detected by bacterial two-hybrid screening. Plasmids were isolated from strains with
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Figure 4. Model of EIIAGlc Activation of Salmonella Type Three
Secretion System 2
EIIAGlc stabilizes the cytosolic part of the secretion apparatus and activates
secretion of effectors.epistasis between crr and TTSS-2 defects. A crrmutant, a ssaGH
mutant lacking crucial structural components of TTSS-2, and a
crr ssaGH double mutant all had similarly strong virulence de-
fects but survived in spleen for 28 days (Figure 1C). The lack of
additive attenuating effects of ssaGH was not due to already
completely abrogated virulence of Salmonella crr, because a
cyaAmutant in the same crr background actually did show exac-
erbated attenuation (Figure 1A). Similarly, the individually
strongly attenuating crrmutation had a very minor additive effect
in ssaGH, in contrast to other mutations such as phoP that show
strong additive effects in TTSS-2 mutants such as ssrB (Beuzo´n
et al., 2001). In absence of a functional TTSS-2, EIIAGlc is thus
largely irrelevant, whereas in absence of EIIAGlc, TTSS-2 has
no impact on Salmonella virulence. These findings strongly sug-
gest that EIIAGlc and TTSS-2 virulence functions are mutually
dependent on each other in agreement with our findings of
EIIAGlc-dependent TTSS-2 secretion/translocation. Major other
EIIAGlc functions apart from TTSS-2 activation are unlikely based
on similar attenuation of ssaGH and ssaGH crr.
In conclusion, EIIAGlc-dependent TTSS-2 activation was
necessary and sufficient to explain the crucial role of EIIAGlc in
Salmonella virulence.
DISCUSSION
This study revealed an unexpected crucial role of the sugar
transport protein and metabolic regulator EIIAGlc in SalmonellaCvirulence. Specifically, EIIAGlc stabilized the crucial cytosolic
part of TTSS-2 and activated TTSS-2 virulence factor secretion
(Figure 4). Further studies are required to unravel the detailed
mechanisms of activation. This is currently hampered by lacking
protocols for purifying functional TTSS-2.
EIIAGlc might also interact with effectors PipB and PipB2, but
this was at most a subordinate function because TTSS-2 secre-
tion was unimpaired in Salmonella pipB pipB2 (Figure S2D).
Moreover, EAIIGlc DN16 interacted equally well with PipB and
PipB2 (Figure S2A), although this EIIAGlc variant did not support
TTSS-2 translocation (Figures 3B and 3C). EIIAGlc interactions
with PipB and PipB2 are thus dispensable and insufficient for
TTSS-2 activation, consistent with weak pipB and pipB2
virulence phenotypes (Knodler et al., 2003; Wood et al., 1998).
EIIAGlc is an abundant protein during infection (Steeb et al.,
2013) and might thus be readily available as a scaffold for
TTSS-2 structural stabilization. In addition, Salmonella might
use EIIAGlc as a metabolic sensor to adjust TTSS-2 activity
and, thereby, virulence/persistence, similarly to TTSS activation
by pH in Salmonella (McGourty et al., 2012) or oxygen tension in
Shigella (Marteyn et al., 2010). Purified functional TTSS-2 com-
plexes and pure EIIAGlc or EIIAGlc-P could help to test these
and alternative hypotheses in future studies.
EIIAGlc represents a potential target for Salmonella control.
This had not previously been recognized due to weak pheno-
types in axenic and cell culture models, but this infection-
specific role could actually be beneficial as inhibition might
have little impact on normal microbiota, whereas abolishing
Salmonella virulence.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Antibodies
Strains derived from Salmonella enterica serovar Typhimurium SL1344
(Hoiseth and Stocker, 1981), plasmids, and antibodies used in this study are
listed in Table S4. Mutants were constructed using lambda red recombinase
(Datsenko and Wanner, 2000) as described in the Supplemental Experimental
Procedures.
Mouse Infections
All animal experiments were approved by Kantonales Veterina¨ramt
Basel-Stadt (license 2239) and performed according to local guidelines
(Tierschutz-Verordnung, Basel-Stadt) and the Swiss animal protection law
(Tierschutz-Gesetz). BALB/cmicewere infected intravenously withSalmonella
as described in the Supplemental Experimental Procedures.
Protein Secretion Assay
TTSS-2 secretion was assayed by precipitation of culture supernatants 90min
after a pH shift from 5.0 to 7.0 (Yu et al., 2010), followed by western blotting as
described in the Supplemental Experimental Procedures.
Coimmunoprecipitation and Mass Spectrometry
Salmonella wild-type and crr-FLAG were cultured in 2-(N-morpholino)ethane-
sulfonic acid (MES)-buffered medium (pH 5.0) and fixed with formaldehyde.
Salmonellawere lysed and incubated with anti-FLAGM2 agarose beads. After
washing, bound proteins were eluted and processed for proteomics as
described in Supplemental Experimental Procedures.
Proteome Comparison
Salmonella wild-type and crr were cultured in MES-buffered medium (pH 5.0)
containing 0.4% of glycerol, processed for proteomics, and analyzed onell Reports 7, 1426–1433, June 12, 2014 ª2014 The Authors 1431
nano-liquid chromatography-tandem mass spectrometry as described in
Supplemental Experimental Procedures.
Bacterial Two-Hybrid Screening
Genomic fragments encoding TTSS-2-associated genes were cloned in
pUT18 (Karimova et al., 1998). crr was fused in frame to the C terminus of
T25 (Karimova et al., 1998), yielding pEIIAGlc-T25. pKT25-zip and pUT18C-
zip were used as positive controls. Interactions were screened in Salmonella
crr cyaA to minimize background. Our analysis was restricted to qualitative
staining patterns on plates because standard b-galactosidase assays could
not be used in Salmonella that lacks this enzyme, and attempts to develop
alternative quantitative assays failed.
Macrophage Cell Culture Infections
RAW264.7 macrophages were infected and analyzed for TTSS-2 effector
translocation using immunofluorescence as described in Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.04.022.
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